[1]
Chapman TM,Perry CM, Cefepime: a review of its use in the management of hospitalized patients with pneumonia. American journal of respiratory medicine : drugs, devices, and other interventions. 2003; [PubMed PMID: 14720024]
[2]
Rivera CG,Narayanan PP,Patel R,Estes LL, Impact of Cefepime Susceptible-Dose-Dependent MIC for Enterobacteriaceae on Reporting and Prescribing. Antimicrobial agents and chemotherapy. 2016 Jun; [PubMed PMID: 27067319]
[3]
Nguyen HM,Shier KL,Graber CJ, Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. The Journal of antimicrobial chemotherapy. 2014 Apr; [PubMed PMID: 24265230]
[4]
The Role of Cefepime in the Treatment of Extended-Spectrum Beta-Lactamase Infections., Patel HB,Lusk KA,Cota JM,, Journal of pharmacy practice, 2017 Jan 1 [PubMed PMID: 29166830]
[5]
Clinical Outcomes of Extended-Spectrum Beta-Lactamase-Producing {i}Enterobacteriaceae{/i} Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems., Walker KJ,Lee YR,Klar AR,, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2018 [PubMed PMID: 29670677]
[6]
Kessler RE, Cefepime microbiologic profile and update. The Pediatric infectious disease journal. 2001 Mar; [PubMed PMID: 11303846]
[7]
Bauer KA,West JE,O'Brien JM,Goff DA, Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections. Antimicrobial agents and chemotherapy. 2013 Jul; [PubMed PMID: 23571547]
[8]
Wrenn RH,Cluck D,Kennedy L,Ohl C,Williamson JC, Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2018 Apr; [PubMed PMID: 28077047]
[9]
Zhu LL,Zhou Q, Optimal infusion rate in antimicrobial therapy explosion of evidence in the last five years. Infection and drug resistance. 2018; [PubMed PMID: 30127628]
[10]
Payne LE,Gagnon DJ,Riker RR,Seder DB,Glisic EK,Morris JG,Fraser GL, Cefepime-induced neurotoxicity: a systematic review. Critical care (London, England). 2017 Nov 14; [PubMed PMID: 29137682]
[11]
Deshayes S,Coquerel A,Verdon R, Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review. Drug safety. 2017 Dec; [PubMed PMID: 28755095]
[12]
Huwyler T,Lenggenhager L,Abbas M,Ing Lorenzini K,Hughes S,Huttner B,Karmime A,Uçkay I,von Dach E,Lescuyer P,Harbarth S,Huttner A, Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2017 Jul; [PubMed PMID: 28111294]
[13]
Isitan C,Ferree A,Hohler AD, Cefepime induced neurotoxicity: A case series and review of the literature. eNeurologicalSci. 2017 Sep; [PubMed PMID: 29260037]
[14]
Appa AA,Jain R,Rakita RM,Hakimian S,Pottinger PS, Characterizing Cefepime Neurotoxicity: A Systematic Review. Open forum infectious diseases. 2017 Fall; [PubMed PMID: 29071284]
[15]
Vorobeichik L,Weber EA,Tarshis J, Misconceptions Surrounding Penicillin Allergy: Implications for Anesthesiologists. Anesthesia and analgesia. 2018 Sep; [PubMed PMID: 29757781]
[17]
Mine Y,Nishida M,Goto S,Kuwahara S, Cefazolin, a new semisynthetic cephalosporin antibiotic. IV. Antigenicity of cefazolin and its cross reactivity with benzylpenicillin, ampicillin and cephaloridine. The Journal of antibiotics. 1970 Apr; [PubMed PMID: 5429508]
[19]
Durand-Maugard C,Lemaire-Hurtel AS,Gras-Champel V,Hary L,Maizel J,Prud'homme-Bernardy A,Andréjak C,Andréjak M, Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports. The Journal of antimicrobial chemotherapy. 2012 May; [PubMed PMID: 22298349]
[20]
Lamoth F,Buclin T,Pascual A,Vora S,Bolay S,Decosterd LA,Calandra T,Marchetti O, High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrobial agents and chemotherapy. 2010 Oct; [PubMed PMID: 20625153]
[21]
Chapuis TM,Giannoni E,Majcherczyk PA,Chioléro R,Schaller MD,Berger MM,Bolay S,Décosterd LA,Bugnon D,Moreillon P, Prospective monitoring of cefepime in intensive care unit adult patients. Critical care (London, England). 2010; [PubMed PMID: 20359352]